According to Vericel 's latest financial reports the company's current EPS (TTM) is -$0.28. In 2022 the company made an earnings per share (EPS) of -$0.35 a decrease over its 2021 EPS that were of -$0.16.
Year | EPS | Change |
---|---|---|
2023 (TTM) | -$0.28 | -20% |
2022 | -$0.35 | 118.75% |
2021 | -$0.16 | -328.57% |
2020 | $0.07000 | -130.43% |
2019 | -$0.23 | 0% |
2018 | -$0.23 | -56.6% |
2017 | -$0.53 | -55.08% |
2016 | -$1.18 | 21.65% |
2015 | -$0.97 | -69.59% |
2014 | -$3.19 | -56.12% |
2013 | -$7.27 | -55.81% |
2012 | -$16.45 | 61.59% |
2011 | -$10.18 | -40.12% |
2010 | -$17.00 | 2.41% |
2009 | -$16.60 | -25.89% |
2008 | -$22.40 | -12.5% |
2007 | -$25.60 | 14.29% |
2006 | -$22.40 | -0% |
2005 | -$22.40 | 16.67% |
2004 | -$19.20 | -25% |
2003 | -$25.60 | -20% |
2002 | -$32.00 | 0% |
2001 | -$32.00 |
Company | EPS | EPS differencediff. | Country |
---|---|---|---|
Royalty Pharma RPRX | $0.55 | -296.43% | ๐ฌ๐ง UK |
Neogen NEOG | -$0.12 | -57.35% | ๐บ๐ธ USA |